<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE TEI.2 SYSTEM "tei_bawe.dtd"><TEI.2 id="_0209d" n="version 1.0"><teiHeader><fileDesc><titleStmt><title>"The regulatory scheme initiated under the Human Fertilisation and Embryology Act 1990 is in need of Review" Discuss.</title></titleStmt><extent/><publicationStmt><distributor>British Academic Written English (BAWE) corpus</distributor><availability><p>The British Academic Written English (BAWE) corpus was developed at the Universities of Warwick, Reading and Oxford Brookes, under the directorship of Hilary Nesi and Sheena Gardner (formerly of the Centre for Applied Linguistics [previously called CELTE], Warwick), Paul Thompson (Department of Applied Linguistics, Reading) and Paul Wickens (Westminster Institute of Education, Oxford Brookes), with funding from the ESRC. Subject to the rights of the these institutions in the BAWE corpus, and pursuant to the ESRC agreement, the BAWE corpus is available to researchers for research purposes PROVIDED THAT the following conditions are met:</p><p>1. The corpus files are not distributed in either their original form or in modified form.</p><p>2. The texts are used for research purposes only; they should not be reproduced in teaching materials.</p><p>3. The texts are not reproduced in full for a wider audience/readership, although researchers are free to quote short passages of text (up to 200 running words from any given text).</p><p>4. The BAWE corpus developers (contact: Hilary Nesi) are informed of all projects, dissertations, theses, presentations or publications arising from analysis of the corpus.</p><p>5. Researchers acknowledge their use of the corpus using the following form of words: "The data in this study come from the British Academic Written English (BAWE) corpus, which was developed at the Universities of Warwick, Reading and Oxford Brookes under the directorship of Hilary Nesi and Sheena Gardner (formerly of the Centre for Applied Linguistics [previously called CELTE], Warwick), Paul Thompson (Department of Applied Linguistics, Reading) and Paul Wickens (Westminster Institute of Education, Oxford Brookes), with funding from the ESRC (RES-000-23-0800)."</p></availability></publicationStmt><notesStmt><note resp="British Academic Written English (BAWE) corpus project">The document has a title page which contains:
document title
title part</note><note resp="British Academic Written English (BAWE) corpus project">deleted: footer: student and page numbers</note><note resp="British Academic Written English (BAWE) corpus project">deleted: 2,500 Words
Excluding References 
Student Number: <name type="student ID"/></note></notesStmt><sourceDesc><p n="level">2</p><p n="date">2004-04</p><p n="module title">Medicine and the Law</p><p n="module code">LA333</p><p n="genre family">Essay</p><p n="discipline">Law</p><p n="disciplinary group">SS</p><p n="grade">D</p><p n="number of authors">1</p><p n="number of words">2817</p><p n="number of s-units">88</p><p n="number of p">18</p><p n="number of tables">0</p><p n="number of figures">0</p><p n="number of block quotes">0</p><p n="number of formulae">0</p><p n="number of lists">0</p><p n="number of paragraphs formatted like lists">2</p><p n="abstract present">no abstract</p><p n="average words per s-unit">32.0</p><p n="average s-units per p">4.9</p><p n="macrotype of assignment">simple assignment</p></sourceDesc></fileDesc><encodingDesc><p>TEI P4 (documented in: BAWE.documentation.pdf)</p></encodingDesc><profileDesc><particDesc><person><p n="gender">m</p><p n="year of birth">1985</p><p n="first language">English</p><p n="education">UKA</p><p n="course">Law LLB</p><p n="student ID">0209</p></person></particDesc></profileDesc></teiHeader><text><front><titlePage><docTitle><titlePart rend="bold">"The regulatory scheme initiated under the Human Fertilisation and Embryology Act 1990 is in need of Review" Discuss. </titlePart></docTitle><titlePart><hi rend="bold">2,500 Word Assignment</hi><hi rend="italic"> Excluding Headings, Sub-titles &amp; References</hi></titlePart><titlePart><name type="student ID"/></titlePart></titlePage><div1 type="front-back-matter"><head rend="bold">N.B. </head><p>As this Assignment was written two important developments were pending:</p><p rend="bulleted">Hashmi decision is awaiting review by the House of Lords</p><p rend="bulleted">The Commons Science and Technology Committee Report on Reproductive Technologies was published on March 24 <hi rend="sup">th</hi> 2005</p></div1></front><body><div1 type="section"><p n="p1.18"><s n="s1.4;p1.18">The HFE<ref target="BAWE_0209d-ftnote.001"/>, established following extensive deliberation under the Warnock Report,<ref target="BAWE_0209d-ftnote.002"/> regulates areas of reproductive medicine. </s><s n="s2.4;p1.18">The creation of new, external reproductive techniques that utilised genetics and once inseparable human constituents as reproductive components, created "a new generation of acute and subtle dilemmas".<ref target="BAWE_0209d-ftnote.003"/> Reproductive medicine; empowering often private, commercial entities, questioned the power, responsibility and motivation of scientists and medical practitioners; probing the limits of accountability "between science, the state, 'society' and capitalism".<ref target="BAWE_0209d-ftnote.004"/> It raised "unparalleled questions for law":<ref target="BAWE_0209d-ftnote.005"/> its role, the protected interests, or indeed whether market-based solutions may be more appropriate than regulation. </s><s n="s3.4;p1.18">Fifteen years later, medicine has developed "exponentially";<ref target="BAWE_0209d-ftnote.006"/> yet regulation remains largely unchanged. </s><s n="s4.4;p1.18">I shall examine, in light of the <hi rend="italic">Hashmi</hi><ref target="BAWE_0209d-ftnote.007"/> and <hi rend="italic">Whitaker</hi> decisions, and the broader context, whether there is a need for review. </s></p><note place="foot" id="BAWE_0209d-ftnote.001"><p n="pn1.1"><s n="s1.1;pn1.1">Human Fertilisation and Embryology Act 1990 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.002"><p n="pn1.1"><s n="s1.1;pn1.1">Warnock Report, conducted under Mary Warnock in 1984 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.003"><p n="pn1.1"><s n="s1.1;pn1.1">Professor John Harris, sourced from ROGER BROWNSWORD, REGULATING HUMAN GENETICS: NEW DILEMMAS FOR A NEW MILLENNIUM, Medical Law Review, 12, Spring, pp. 14 - 39 © Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.004"><p n="pn1.1"><s n="s1.1;pn1.1">SAMANTHA HALLIDAY AND DEBORAH LYNN STEINBERG, THE REGULATED GENE: NEW LEGAL DILEMMAS, Medical Law Review, 12, Spring, pp. 2 - 13 © Oxford University Press 2004; all rights reserved. </s></p></note><note place="foot" id="BAWE_0209d-ftnote.005"><p n="pn1.1"><s n="s1.1;pn1.1">SAMANTHA HALLIDAY AND DEBORAH LYNN STEINBERG, THE REGULATED GENE: NEW LEGAL DILEMMAS, Medical Law Review, 12, Spring, pp. 2 - 13 © Oxford University Press 2004; all rights reserved. </s></p></note><note place="foot" id="BAWE_0209d-ftnote.006"><p n="pn1.1"><s n="s1.1;pn1.1">Robert G. Lee and Derek Morgan, Human Fertilisation and Embryology, Regulating the Reproductive Revolution, Blackstone Press Limited, 1st Edition, printed in 2001 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.007"><p n="pn1.1"><s n="s1.1;pn1.1">R ex parte Quintavelle v HFEA </s></p></note><p n="p2.18"><s n="s1.8;p2.18">Legal responses can be categorized as either "pro-regulation"<ref target="BAWE_0209d-ftnote.008"/> (e.g. </s><s n="s2.8;p2.18">UK), which controls, confines and operates within a highly structured scheme; or "anti-regulation"<ref target="BAWE_0209d-ftnote.009"/> (e.g. </s><s n="s3.8;p2.18">US), which operates "ex post, endeavoring to compensate and adjust"<ref target="BAWE_0209d-ftnote.010"/> to technological advances. </s><s n="s4.8;p2.18">Law should provide "legitimacy",<ref target="BAWE_0209d-ftnote.011"/> promoting "acceptable boundaries"<ref target="BAWE_0209d-ftnote.012"/> for developments. </s><s n="s5.8;p2.18">However, this legitimacy can "often owe more to <hi rend="italic">Realpolitik</hi>",<ref target="BAWE_0209d-ftnote.013"/> than that crafted through moral reasoning, debate and consensus; particularly when this 'legislative legitimacy' varies between legal jurisdictions.<ref target="BAWE_0209d-ftnote.014"/> Legal regulation questions the very fabric of morality. </s><s n="s6.8;p2.18">Since this is a diverse rather than homogenous entity, consensus on a moral, let alone legal level is improbable. </s><s n="s7.8;p2.18">Law must either convey an ideological, predictable and determinate approach or react with "pragmatism",<ref target="BAWE_0209d-ftnote.015"/> on an ad hoc basis to new issues. </s><s n="s8.8;p2.18">These considerations affect law's response to the two fundamental, "competing (and often conflicting) interests":<ref target="BAWE_0209d-ftnote.016"/> research and its potential benefits, versus morality and safety; what Brownsword names the "regulatory tilt". <ref target="BAWE_0209d-ftnote.017"/> </s></p><note place="foot" id="BAWE_0209d-ftnote.008"><p n="pn1.1"><s n="s1.1;pn1.1">ROGER BROWNSWORD, REGULATING HUMAN GENETICS: NEW DILEMMAS FOR A NEW MILLENNIUM, Medical Law Review, 12, Spring, pp. 14 - 39 © Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.009"><p n="pn1.1"><s n="s1.1;pn1.1">ROGER BROWNSWORD, REGULATING HUMAN GENETICS: NEW DILEMMAS FOR A NEW MILLENNIUM, Medical Law Review, 12, Spring, pp. 14 - 39 © Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.010"><p n="pn1.1"><s n="s1.1;pn1.1">ROGER BROWNSWORD, REGULATING HUMAN GENETICS: NEW DILEMMAS FOR A NEW MILLENNIUM, Medical Law Review, 12, Spring, pp. 14 - 39 © Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.011"><p n="pn1.1"><s n="s1.1;pn1.1">Deech, sourced from SAMANTHA HALLIDAY AND DEBORAH LYNN STEINBERG, THE REGULATED GENE: NEW LEGAL DILEMMAS, Medical Law Review, 12, Spring, pp. 2 - 13 © Oxford University Press 2004; all rights reserved. </s></p></note><note place="foot" id="BAWE_0209d-ftnote.012"><p n="pn1.1"><s n="s1.1;pn1.1">Deech, sourced from SAMANTHA HALLIDAY AND DEBORAH LYNN STEINBERG, THE REGULATED GENE: NEW LEGAL DILEMMAS, Medical Law Review, 12, Spring, pp. 2 - 13 © Oxford University Press 2004; all rights reserved. </s></p></note><note place="foot" id="BAWE_0209d-ftnote.013"><p n="pn1.1"><s n="s1.1;pn1.1"><hi rend="italic">(Emphasis original)</hi> SAMANTHA HALLIDAY AND DEBORAH LYNN STEINBERG, THE REGULATED GENE: NEW LEGAL DILEMMAS, Medical Law Review, 12, Spring, pp. 2 - 13 © Oxford University Press 2004; all rights reserved. </s></p></note><note place="foot" id="BAWE_0209d-ftnote.014"><p n="pn1.1"><s n="s1.1;pn1.1">Idea from SAMANTHA HALLIDAY AND DEBORAH LYNN STEINBERG, THE REGULATED GENE: NEW LEGAL DILEMMAS, Medical Law Review, 12, Spring, pp. 2 - 13 © Oxford University Press 2004; all rights reserved. </s></p></note><note place="foot" id="BAWE_0209d-ftnote.015"><p n="pn1.1"><s n="s1.1;pn1.1">Margaret Brazier, Regulating the Reproduction business, Medical Law Review, 7, Summer 1999, pp. 166-193 © Oxford University Press </s></p></note><note place="foot" id="BAWE_0209d-ftnote.016"><p n="pn1.1"><s n="s1.1;pn1.1">SAMANTHA HALLIDAY AND DEBORAH LYNN STEINBERG, THE REGULATED GENE: NEW LEGAL DILEMMAS, Medical Law Review, 12, Spring, pp. 2 - 13 © Oxford University Press 2004; all rights reserved. </s></p></note><note place="foot" id="BAWE_0209d-ftnote.017"><p n="pn1.1"><s n="s1.1;pn1.1">ROGER BROWNSWORD, REGULATING HUMAN GENETICS: NEW DILEMMAS FOR A NEW MILLENNIUM, Medical Law Review, 12, Spring, pp. 14 - 39 © Oxford University Press 2004 </s></p></note><p n="p3.18"><s n="s1.6;p3.18">Warnock recommended an independent and "comprehensive scheme of regulation"<ref target="BAWE_0209d-ftnote.018"/> was required for <hi rend="italic">specific</hi> reproductive technologies; including an advisory/licensing agency to ensure: quality, protection, and safety. </s><s n="s2.6;p3.18">The HFE limits reproductive technologies and research involving embryos, placing them in "strictly defined ethical and legal backgrounds".<ref target="BAWE_0209d-ftnote.019"/> It prohibits the creation of embryos outside the body and storage of gametes without a licence; whilst S3<ref target="BAWE_0209d-ftnote.020"/> restricts licence-holder's use of embryos. </s><s n="s3.6;p3.18">It bestows significant powers to a regulatory authority, the HFEA,<ref target="BAWE_0209d-ftnote.021"/> which supervises the licensing process. </s><s n="s4.6;p3.18">Licenses permit clinics to provide subscribed treatment services (e.g. </s><s n="s5.6;p3.18">IVF), or to store or research on embryos/gametes. </s><s n="s6.6;p3.18">Under Schedule Two S3(1), the HFEA can grant licences only where "research is necessary or desirable",<ref target="BAWE_0209d-ftnote.022"/> which: advances infertility treatment, "knowledge about the causes of congenital disease"<ref target="BAWE_0209d-ftnote.023"/> or "miscarriages";<ref target="BAWE_0209d-ftnote.024"/> develops "more effective...contraception",<ref target="BAWE_0209d-ftnote.025"/> or "methods for detecting...gene/chromosome abnormalities". <ref target="BAWE_0209d-ftnote.026"/> </s></p><note place="foot" id="BAWE_0209d-ftnote.018"><p n="pn1.1"><s n="s1.1;pn1.1">Warnock Report, sourced from Margaret Brazier, Regulating the Reproduction business, Medical Law Review, 7, Summer 1999, pp. 166-193 © Oxford University Press </s></p></note><note place="foot" id="BAWE_0209d-ftnote.019"><p n="pn1.2"><s n="s1.1;pn1.2">Aurora Plomer, Beyond the HFEA 1990 - The Regulation of Stem cell Research in the UK, </s></p><p n="pn2.2"><s n="s1.1;pn2.2">Medical Law Review, 10 Summer 2002, pp132-164, © Oxford University Press </s></p></note><note place="foot" id="BAWE_0209d-ftnote.020"><p n="pn1.1"><s n="s1.1;pn1.1">Section 3, Human Fertilisation and Embryology Act 1990 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.021"><p n="pn1.1"><s n="s1.1;pn1.1">Human Fertilisation and Embryology Authority </s></p></note><note place="foot" id="BAWE_0209d-ftnote.022"><p n="pn1.2"><s n="s1.1;pn1.2">Aurora Plomer, Beyond the HFEA 1990 - The Regulation of Stem cell Research in the UK, </s></p><p n="pn2.2"><s n="s1.1;pn2.2">Medical Law Review, 10 Summer 2002, pp132-164, © Oxford University Press </s></p></note><note place="foot" id="BAWE_0209d-ftnote.023"><p n="pn1.1"><s n="s1.1;pn1.1">Schedule 2 S3 (1) HFE Act 1990 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.024"><p n="pn1.1"><s n="s1.1;pn1.1">Schedule 2 S3 (1) HFE Act 1990 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.025"><p n="pn1.1"><s n="s1.1;pn1.1">Schedule 2 S3 (1) HFE Act 1990 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.026"><p n="pn1.1"><s n="s1.1;pn1.1">Schedule 2 S3 (1) HFE Act 1990 </s></p></note><p n="p4.18"><s n="s1.4;p4.18">Legal intervention from a fixed perspective "distorts"<ref target="BAWE_0209d-ftnote.027"/> sciences' "essentially fluid, dynamic nature;"<ref target="BAWE_0209d-ftnote.028"/> constructing "hard law"<ref target="BAWE_0209d-ftnote.029"/> that as science develops, leaves regulatory provisions behind. </s><s n="s2.4;p4.18">Regulation therefore needs to "incorporate a degree of flexibility or open-endedness",<ref target="BAWE_0209d-ftnote.030"/> to maintain "regulatory connection"<ref target="BAWE_0209d-ftnote.031"/> between science and law, even though this can "militate against predictability and consistency".<ref target="BAWE_0209d-ftnote.032"/> By establishing an autonomous authority with significant, devolved power that is "built on [a] consensus"<ref target="BAWE_0209d-ftnote.033"/> between medical regulators, clinics and scientists; the UK's scheme combines elements of these theories. </s><s n="s3.4;p4.18">Whilst the HFE provides a fixed position, perhaps reflecting some core, minimum ethical standards rather than adopting an ideological perspective; the HFEA is more adaptive; and combined with the courts is prepared to purposively interpret provisions, asserting to provide a "high degree of public accountability in the development and delivery of new treatments and research".<ref target="BAWE_0209d-ftnote.034"/> The government claim to have created a "robust and proportionate regulatory framework [that]...anticipates and continues to address public concerns".<ref target="BAWE_0209d-ftnote.035"/> It is this notion I seek to challenge. </s><s n="s4.4;p4.18">No single regulatory framework for genetics exists, whilst the HFE has no "single, coherent philosophical underpin".<ref target="BAWE_0209d-ftnote.036"/> Consequently, as technology has developed beyond expectation, law has become reactive and fraught with "contradiction". <ref target="BAWE_0209d-ftnote.037"/> </s></p><note place="foot" id="BAWE_0209d-ftnote.027"><p n="pn1.1"><s n="s1.1;pn1.1">Lee and Morgan, sourced from SAMANTHA HALLIDAY AND DEBORAH LYNN STEINBERG, THE REGULATED GENE: NEW LEGAL DILEMMAS, Medical Law Review, 12, Spring, pp. 2 - 13 © Oxford University Press 2004; all rights reserved. </s></p></note><note place="foot" id="BAWE_0209d-ftnote.028"><p n="pn1.1"><s n="s1.1;pn1.1">Lee and Morgan, sourced from SAMANTHA HALLIDAY AND DEBORAH LYNN STEINBERG, THE REGULATED GENE: NEW LEGAL DILEMMAS, Medical Law Review, 12, Spring, pp. 2 - 13 © Oxford University Press 2004; all rights reserved. </s></p></note><note place="foot" id="BAWE_0209d-ftnote.029"><p n="pn1.1"><s n="s1.1;pn1.1">ROGER BROWNSWORD, REGULATING HUMAN GENETICS: NEW DILEMMAS FOR A NEW MILLENNIUM, Medical Law Review, 12, Spring, pp. 14 - 39 © Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.030"><p n="pn1.1"><s n="s1.1;pn1.1">ROGER BROWNSWORD, REGULATING HUMAN GENETICS: NEW DILEMMAS FOR A NEW MILLENNIUM, Medical Law Review, 12, Spring, pp. 14 - 39 © Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.031"><p n="pn1.1"><s n="s1.1;pn1.1">ROGER BROWNSWORD, REGULATING HUMAN GENETICS: NEW DILEMMAS FOR A NEW MILLENNIUM, Medical Law Review, 12, Spring, pp. 14 - 39 © Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.032"><p n="pn1.1"><s n="s1.1;pn1.1">SAMANTHA HALLIDAY AND DEBORAH LYNN STEINBERG, THE REGULATED GENE: NEW LEGAL DILEMMAS, Medical Law Review, 12, Spring, pp. 2 - 13 © Oxford University Press 2004; all rights reserved. </s></p></note><note place="foot" id="BAWE_0209d-ftnote.033"><p n="pn1.1"><s n="s1.1;pn1.1">Robert G. Lee and Derek Morgan, Human Fertilisation and Embryology, Regulating the Reproductive Revolution, Blackstone Press Limited, 1st Edition, printed in 2001 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.034"><p n="pn1.1"><s n="s1.1;pn1.1">Robert G. Lee and Derek Morgan, Human Fertilisation and Embryology, Regulating the Reproductive Revolution, Blackstone Press Limited, 1st Edition, printed in 2001 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.035"><p n="pn1.1"><s n="s1.1;pn1.1">White Paper, <hi rend="italic">Our Inheritance, Our Future</hi> </s></p></note><note place="foot" id="BAWE_0209d-ftnote.036"><p n="pn1.1"><s n="s1.1;pn1.1">Margaret Brazier, Regulating the Reproduction business, Medical Law Review, 7, Summer 1999, pp. 166-193 © Oxford University Press </s></p></note><note place="foot" id="BAWE_0209d-ftnote.037"><p n="pn1.1"><s n="s1.1;pn1.1">Margaret Brazier, Regulating the Reproduction business, Medical Law Review, 7, Summer 1999, pp. 166-193 © Oxford University Press </s></p></note><p n="p5.18"><s n="s1.10;p5.18">CNR,<ref target="BAWE_0209d-ftnote.038"/> a reproductive cloning technique using egg rather than a cell substitution, illustrated the need to refresh law to maintain regulatory connection. </s><s n="s2.10;p5.18">CNR was not envisaged under the HFE, which expressly prohibited 'cell substitution' cloning.<ref target="BAWE_0209d-ftnote.039"/> However, HGAC<ref target="BAWE_0209d-ftnote.040"/> and HFEA believed that as CNR involved the creation of embryos outside the body, it fell "within the HFE",<ref target="BAWE_0209d-ftnote.041"/> and therefore the HFEA's jurisdiction. </s><s n="s3.10;p5.18">This imprecise, "purposive"<ref target="BAWE_0209d-ftnote.042"/> interpretation implied that eggs were included within the definition of embryos; giving effect to Parliament's intention to prohibit cloning. </s><s n="s4.10;p5.18">Realistically, CNR was not "specifically"<ref target="BAWE_0209d-ftnote.043"/> excluded by S3(3)(d):<ref target="BAWE_0209d-ftnote.044"/> it did not involve fertilisation (replacement rather than fusion). </s><s n="s5.10;p5.18">The HFE defines embryos as where "fertilisation is complete",<ref target="BAWE_0209d-ftnote.045"/> which "includes eggs in the process of fertilisation".<ref target="BAWE_0209d-ftnote.046"/> However, as Wilmut asserts, CNR oocytes would never be fertilised "because the nucleus is transferred into it".<ref target="BAWE_0209d-ftnote.047"/> It was questionable whether CNR was at all regulated. </s><s n="s6.10;p5.18">The Donaldson Report<ref target="BAWE_0209d-ftnote.048"/> however endorsed the HFEA's position, "understating"<ref target="BAWE_0209d-ftnote.049"/> the difficulty in asserting precise regulatory parameters. </s><s n="s7.10;p5.18">CNR was not prohibited, but licensable; a <hi rend="italic">convenient</hi> proposition which the government accepted: the HFE was inadequate to regulate a perilous technique; but the HFEA could side-step the issue by refusing CNR licences. </s><s n="s8.10;p5.18">It is this sense of 'make do and mend' that characterises recent regulatory development. </s><s n="s9.10;p5.18">Fortunately, the HRC<ref target="BAWE_0209d-ftnote.050"/> was later enacted (prohibiting CNR) following a ruling<ref target="BAWE_0209d-ftnote.051"/> that CNR was unregulated. </s><s n="s10.10;p5.18">It serves as a presiding example of law introducing "control mechanisms only after scientific excess";<ref target="BAWE_0209d-ftnote.052"/> its unhurried reaction and attempts to use existing structures to remedy issues deserving of more significant response. </s></p><note place="foot" id="BAWE_0209d-ftnote.038"><p n="pn1.1"><s n="s1.1;pn1.1">Cell Nuclear Replacement </s></p></note><note place="foot" id="BAWE_0209d-ftnote.039"><p n="pn1.1"><s n="s1.1;pn1.1">Cloning is expressly prohibited under S3 (3) (d) HFE Act 1990 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.040"><p n="pn1.1"><s n="s1.1;pn1.1">Human Genetics Advisory Commission </s></p></note><note place="foot" id="BAWE_0209d-ftnote.041"><p n="pn1.2"><s n="s1.1;pn1.2">Aurora Plomer, Beyond the HFEA 1990 - The Regulation of Stem cell Research in the UK, </s></p><p n="pn2.2"><s n="s1.1;pn2.2">Medical Law Review, 10 Summer 2002, pp132-164, © Oxford University Press </s></p></note><note place="foot" id="BAWE_0209d-ftnote.042"><p n="pn1.1"><s n="s1.1;pn1.1">ROGER BROWNSWORD, REGULATING HUMAN GENETICS: NEW DILEMMAS FOR A NEW MILLENNIUM, Medical Law Review, 12, Spring, pp. 14 - 39 © Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.043"><p n="pn1.1"><s n="s1.1;pn1.1">ROGER BROWNSWORD, REGULATING HUMAN GENETICS: NEW DILEMMAS FOR A NEW MILLENNIUM, Medical Law Review, 12, Spring, pp. 14 - 39 © Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.044"><p n="pn1.1"><s n="s1.1;pn1.1">Cloning is expressly prohibited under S3 (3) (d) HFE Act 1990 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.045"><p n="pn1.1"><s n="s1.1;pn1.1">S1 HFE Act 1990 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.046"><p n="pn1.1"><s n="s1.1;pn1.1">S1 HFE Act 1990 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.047"><p n="pn1.2"><s n="s1.1;pn1.2">Wilmut, sourced from Aurora Plomer, Beyond the HFEA 1990 - The Regulation of Stem cell Research in the UK, </s></p><p n="pn2.2"><s n="s1.1;pn2.2">Medical Law Review, 10 Summer 2002, pp132-164, © Oxford University Press </s></p></note><note place="foot" id="BAWE_0209d-ftnote.048"><p n="pn1.1"><s n="s1.1;pn1.1">Donaldson Report, 2001 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.049"><p n="pn1.2"><s n="s1.1;pn1.2">Aurora Plomer, Beyond the HFEA 1990 - The Regulation of Stem cell Research in the UK, </s></p><p n="pn2.2"><s n="s1.1;pn2.2">Medical Law Review, 10 Summer 2002, pp132-164, © Oxford University Press </s></p></note><note place="foot" id="BAWE_0209d-ftnote.050"><p n="pn1.1"><s n="s1.1;pn1.1">Human Reproductive Cloning Act, 2001 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.051"><p n="pn1.1"><s n="s1.1;pn1.1">As per Crane J; R (on the application of Quintavalle) v Secretary of State for Health (2001) 4 All E.R. 1013 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.052"><p n="pn1.1"><s n="s1.1;pn1.1">SAMANTHA HALLIDAY AND DEBORAH LYNN STEINBERG, THE REGULATED GENE: NEW LEGAL DILEMMAS, Medical Law Review, 12, Spring, pp. 2 - 13 © Oxford University Press 2004 </s></p></note><p n="p6.18"><s n="s1.4;p6.18">The forced interpretation used in <hi rend="italic">Hashmi</hi><ref target="BAWE_0209d-ftnote.053"/> illustrated the HFE's "outdated"<ref target="BAWE_0209d-ftnote.054"/> and compromised status. </s><s n="s2.4;p6.18">The <hi rend="italic">Hashmis</hi> wished to select embryos to produce a child bearing suitable tissue to cure their son who suffered with BT.<ref target="BAWE_0209d-ftnote.055"/> PGD<ref target="BAWE_0209d-ftnote.056"/>, a process which detects genetic anomalies to ensure only healthy embryos are selected for reproduction, had been commonly permitted by the HFEA. The <hi rend="italic">Hashmis</hi> wanted to extend this process to include HLA<ref target="BAWE_0209d-ftnote.057"/> tissue-typing to select a suitable tissue match. </s><s n="s3.4;p6.18">The HFEA permitted this, stating that where "PGD is already undertaken...the use of tissue typing to save the life of a sibling can be justified",<ref target="BAWE_0209d-ftnote.058"/> albeit in "rare circumstances and under strict controls". </s><ref target="BAWE_0209d-ftnote.059"/><s n="s4.4;p6.18">CORE<ref target="BAWE_0209d-ftnote.060"/> requested a JR,<ref target="BAWE_0209d-ftnote.061"/> arguing the HFEA "had gone beyond the HFE;"<ref target="BAWE_0209d-ftnote.062"/> permitting a practice that was not "designed to help women carry children,"<ref target="BAWE_0209d-ftnote.063"/> which subsequently could not be licensed. </s></p><note place="foot" id="BAWE_0209d-ftnote.053"><p n="pn1.1"><s n="s1.1;pn1.1">R ex parte Quintavelle v HFEA </s></p></note><note place="foot" id="BAWE_0209d-ftnote.054"><p n="pn1.1"><s n="s1.1;pn1.1">Beverley Mulvenna, Pre-Implantation genetic diagnosis, Tissues typing and beyond: the legal implications of the Hashmi case, Medical Law International 2004, Vol. 6, pp.163-182, AB Academic Publishers, </s></p></note><note place="foot" id="BAWE_0209d-ftnote.055"><p n="pn1.1"><s n="s1.1;pn1.1">Beta Thassaemia </s></p></note><note place="foot" id="BAWE_0209d-ftnote.056"><p n="pn1.1"><s n="s1.1;pn1.1">Pre-implantation Genetic Diagnosis </s></p></note><note place="foot" id="BAWE_0209d-ftnote.057"><p n="pn1.1"><s n="s1.1;pn1.1">Human Leukocyte Antigen Tissue Typing </s></p></note><note place="foot" id="BAWE_0209d-ftnote.058"><p n="pn1.1"><s n="s1.1;pn1.1">HFEA Statement: </s></p></note><note place="foot" id="BAWE_0209d-ftnote.059"><p n="pn1.1"><s n="s1.1;pn1.1">HFEA Statement: </s></p></note><note place="foot" id="BAWE_0209d-ftnote.060"><p n="pn1.1"><s n="s1.1;pn1.1">Acronym: Comment On Reproductive Ethics </s></p></note><note place="foot" id="BAWE_0209d-ftnote.061"><p n="pn1.1"><s n="s1.1;pn1.1">Judicial Review </s></p></note><note place="foot" id="BAWE_0209d-ftnote.062"><p n="pn1.1"><s n="s1.1;pn1.1">CORE, sourced from R ex parte Quintavelle v HFEA </s></p></note><note place="foot" id="BAWE_0209d-ftnote.063"><p n="pn1.1"><s n="s1.1;pn1.1">CORE, sourced from R ex parte Quintavelle v HFEA </s></p></note><p n="p7.18"><s n="s1.6;p7.18">However, Kay's<ref target="BAWE_0209d-ftnote.064"/> initial High Court judgement highlighted an unexpected "flaw in the act's drafting":<ref target="BAWE_0209d-ftnote.065"/> PGD was not, <hi rend="italic">prima facie</hi>, a licensable "treatment service".<ref target="BAWE_0209d-ftnote.066"/> Yet in common with practice, PGD <hi rend="italic">had</hi> been permitted, illustrating the potentially limiting effect of legislation clearly in need of revision. </s><s n="s2.6;p7.18">In an attempt to justify/secure PGD, the court considered whether under the "restrictive"<ref target="BAWE_0209d-ftnote.067"/> definition of "treatment services"<ref target="BAWE_0209d-ftnote.068"/> ("assisting women to carry children"<ref target="BAWE_0209d-ftnote.069"/>), PGD <hi rend="italic">assisted</hi> women to carry children. </s><s n="s3.6;p7.18">Kay asserted that under Schedule-Two<ref target="BAWE_0209d-ftnote.070"/> embryos must be "suitable for being placed within a woman;"<ref target="BAWE_0209d-ftnote.071"/> and as PGD guarantees suitability, it was permissible. </s><s n="s4.6;p7.18">However, the Court of Appeal's judgement overcame these difficulties by using "an approach to statutory interpretation that was not just purposive but creative".<ref target="BAWE_0209d-ftnote.072"/> Following <hi rend="italic">Pepper v Hart</hi>,<ref target="BAWE_0209d-ftnote.073"/> legislation which is "ambiguous or obscure or [where] the literal meaning...leads to absurdity",<ref target="BAWE_0209d-ftnote.074"/> may be interpreted in context with Parliamentary intention. </s><s n="s5.6;p7.18">Consequently, the court<ref target="BAWE_0209d-ftnote.075"/> used a resourceful, 'back door entrance' to secure PGD's use; arguing it was envisaged under the HFE as it had been "universally assumed that it was licensable";<ref target="BAWE_0209d-ftnote.076"/> therefore, a contrary literal interpretation would lead to "absurdity".<ref target="BAWE_0209d-ftnote.077"/> PGD is a necessary procedure in reproductive medicine to prevent genetic defects. </s><s n="s6.6;p7.18">Clearly considerable uncertainty exists whether it is licensable; an extremely undesirable position. </s></p><note place="foot" id="BAWE_0209d-ftnote.064"><p n="pn1.1"><s n="s1.1;pn1.1">Kay LJ </s></p></note><note place="foot" id="BAWE_0209d-ftnote.065"><p n="pn1.1"><s n="s1.1;pn1.1">Beverley Mulvenna, Pre-Implantation genetic diagnosis, Tissues typing and beyond: the legal implications of the Hashmi case, Medical Law International 2004, Vol. 6, pp.163-182, AB Academic Publishers, </s></p></note><note place="foot" id="BAWE_0209d-ftnote.066"><p n="pn1.1"><s n="s1.1;pn1.1">Treatment service under S11(1) </s></p></note><note place="foot" id="BAWE_0209d-ftnote.067"><p n="pn1.1"><s n="s1.1;pn1.1">Beverley Mulvenna, Pre-Implantation genetic diagnosis, Tissues typing and beyond: the legal implications of the Hashmi case, Medical Law International 2004, Vol. 6, pp.163-182, AB Academic Publishers, </s></p></note><note place="foot" id="BAWE_0209d-ftnote.068"><p n="pn1.1"><s n="s1.1;pn1.1">Under S HFE Act 1990 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.069"><p n="pn1.1"><s n="s1.1;pn1.1">S2(1) HFE Act 1990 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.070"><p n="pn1.1"><s n="s1.1;pn1.1">Schedule Two, HFE Act 1990 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.071"><p n="pn1.1"><s n="s1.1;pn1.1">Schedule 2, HFE Act 1990 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.072"><p n="pn1.1"><s n="s1.1;pn1.1">Beverley Mulvenna, Pre-Implantation genetic diagnosis, Tissues typing and beyond: the legal implications of the Hashmi case, Medical Law International 2004, Vol. 6, pp.163-182, AB Academic Publishers, </s></p></note><note place="foot" id="BAWE_0209d-ftnote.073"><p n="pn1.1"><s n="s1.1;pn1.1">Pepper v Hart (1993) 1 All ER42 CA </s></p></note><note place="foot" id="BAWE_0209d-ftnote.074"><p n="pn1.1"><s n="s1.1;pn1.1">Pepper v Hart (1993) 1 All ER42 CA </s></p></note><note place="foot" id="BAWE_0209d-ftnote.075"><p n="pn1.1"><s n="s1.1;pn1.1">Court of Appeal </s></p></note><note place="foot" id="BAWE_0209d-ftnote.076"><p n="pn1.1"><s n="s1.1;pn1.1">Beverley Mulvenna, Pre-Implantation genetic diagnosis, Tissues typing and beyond: the legal implications of the Hashmi case, Medical Law International 2004, Vol. 6, pp.163-182, AB Academic Publishers, </s></p></note><note place="foot" id="BAWE_0209d-ftnote.077"><p n="pn1.1"><s n="s1.1;pn1.1">Beverley Mulvenna, Pre-Implantation genetic diagnosis, Tissues typing and beyond: the legal implications of the Hashmi case, Medical Law International 2004, Vol. 6, pp.163-182, AB Academic Publishers, </s></p></note><p n="p8.18"><s n="s1.5;p8.18">The Court of Appeal's responses to the HFEA's arguments for HLA were "less than satisfactory".<ref target="BAWE_0209d-ftnote.078"/> The HFEA firstly contested that HLA did not require a licence as it used <hi rend="italic">cells from</hi> embryos, rather <hi rend="italic">than</hi> embryos. </s><s n="s2.5;p8.18">In agreement, Schiemann<ref target="BAWE_0209d-ftnote.079"/> inferred that HLA and PGD were similar; subsequently neither fell within the "prohibited area"<ref target="BAWE_0209d-ftnote.080"/> of illegal practices. </s><s n="s3.5;p8.18">This "misses the point":<ref target="BAWE_0209d-ftnote.081"/> just because testing for genetic abnormalities was not considered to be objectionable "fails to justify tissue typing,"<ref target="BAWE_0209d-ftnote.082"/> as HLA does not identify genetic defects. </s><s n="s4.5;p8.18">Fortunately, Mance<ref target="BAWE_0209d-ftnote.083"/> rejected the HFEA's argument as licences cannot be granted where one of the two purposes (HLA/PGD) fall outside the act. </s><s n="s5.5;p8.18">Otherwise, where PGD had been permitted to prevent genetic anomalies, clinics would be able to screen cells for other characteristics, "including sex",<ref target="BAWE_0209d-ftnote.084"/> enabling those parents access to "a range of tests that were forbidden to others"; <ref target="BAWE_0209d-ftnote.085"/> an undesirable outcome. </s></p><note place="foot" id="BAWE_0209d-ftnote.078"><p n="pn1.1"><s n="s1.1;pn1.1">Beverley Mulvenna, Pre-Implantation genetic diagnosis, Tissues typing and beyond: the legal implications of the Hashmi case, Medical Law International 2004, Vol. 6, pp.163-182, AB Academic Publishers, </s></p></note><note place="foot" id="BAWE_0209d-ftnote.079"><p n="pn1.1"><s n="s1.1;pn1.1">Schiemann LJ </s></p></note><note place="foot" id="BAWE_0209d-ftnote.080"><p n="pn1.1"><s n="s1.1;pn1.1">Schiemann LJ, R ex parte Quintavelle v HFEA </s></p></note><note place="foot" id="BAWE_0209d-ftnote.081"><p n="pn1.1"><s n="s1.1;pn1.1">Beverley Mulvenna, Pre-Implantation genetic diagnosis, Tissues typing and beyond: the legal implications of the Hashmi case, Medical Law International 2004, Vol. 6, pp.163-182, AB Academic Publishers, </s></p></note><note place="foot" id="BAWE_0209d-ftnote.082"><p n="pn1.1"><s n="s1.1;pn1.1">Beverley Mulvenna, Pre-Implantation genetic diagnosis, Tissues typing and beyond: the legal implications of the Hashmi case, Medical Law International 2004, Vol. 6, pp.163-182, AB Academic Publishers, </s></p></note><note place="foot" id="BAWE_0209d-ftnote.083"><p n="pn1.1"><s n="s1.1;pn1.1">Mance LJ </s></p></note><note place="foot" id="BAWE_0209d-ftnote.084"><p n="pn1.1"><s n="s1.2;pn1.1">Sally Sheldon and Stephen Wilkinson, Hashmi and Whitaker, an unjustifiable and misguided distinction? </s><s n="s2.2;pn1.1">Medical Law Review, 12, Summer 2004, pp.137-163, Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.085"><p n="pn1.1"><s n="s1.2;pn1.1">Sally Sheldon and Stephen Wilkinson, Hashmi and Whitaker, an unjustifiable and misguided distinction? </s><s n="s2.2;pn1.1">Medical Law Review, 12, Summer 2004, pp.137-163, Oxford University Press 2004 </s></p></note><p n="p9.18"><s n="s1.4;p9.18">The HFEA argued HLA <hi rend="italic">could</hi> be licensed if its use was "desirable for the purpose of rendering treatment services;" and to the overall provision of fertility treatments. </s><s n="s2.4;p9.18">CORE challenged this, stating treatments should only available if necessary to "assist women [to] carry children";<ref target="BAWE_0209d-ftnote.086"/> a literal interpretation of the HFE. The court<ref target="BAWE_0209d-ftnote.087"/> adopted the HFEA's "purposive"<ref target="BAWE_0209d-ftnote.088"/> approach. </s><s n="s3.4;p9.18">Lord Phillips<ref target="BAWE_0209d-ftnote.089"/> suggested Schedule Two<ref target="BAWE_0209d-ftnote.090"/> permitted research which develops "methods for detecting...gene or chromosome abnormalities,"<ref target="BAWE_0209d-ftnote.091"/> therefore allowing PGD as it may <hi rend="italic">assist</hi> women by preventing defects. </s><s n="s4.4;p9.18">Subsequently, Phillips claims the only difference between PGD and HLA was "the desired characteristics"<ref target="BAWE_0209d-ftnote.092"/> that were selected (healthy vs. tissue match), and that HLA "would assist some women who would otherwise refrain from conception";<ref target="BAWE_0209d-ftnote.093"/> declaring the difference "cannot be important".<ref target="BAWE_0209d-ftnote.094"/> Realistically, he "stretched the statutory provisions beyond...[what]...could be reasonably justified",<ref target="BAWE_0209d-ftnote.095"/> presenting an oversimplified analysis that should not, and "could not apply to tissue typing"'.<ref target="BAWE_0209d-ftnote.096"/> From this tiny, yet gauche distinction he makes an exceptionally important moral statement, taking reproductive law into un-chartered territory; "a dangerous first step towards allowing...parents to choose characteristics of [their] baby, such as eye colour and sex". <ref target="BAWE_0209d-ftnote.097"/> </s></p><note place="foot" id="BAWE_0209d-ftnote.086"><p n="pn1.1"><s n="s1.1;pn1.1">CORE on the HFE Act 1990 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.087"><p n="pn1.1"><s n="s1.1;pn1.1">Court of Appeal </s></p></note><note place="foot" id="BAWE_0209d-ftnote.088"><p n="pn1.1"><s n="s1.2;pn1.1">Sally Sheldon and Stephen Wilkinson, Hashmi and Whitaker, an unjustifiable and misguided distinction? </s><s n="s2.2;pn1.1">Medical Law Review, 12, Summer 2004, pp.137-163, Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.089"><p n="pn1.1"><s n="s1.1;pn1.1">Lord Phillips MR </s></p></note><note place="foot" id="BAWE_0209d-ftnote.090"><p n="pn1.1"><s n="s1.1;pn1.1">Schedule Two, paragraph 3 (2) (b) HFE Act 1990 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.091"><p n="pn1.1"><s n="s1.1;pn1.1">Lord Phillips MR, R ex parte Quintavelle v HFEA </s></p></note><note place="foot" id="BAWE_0209d-ftnote.092"><p n="pn1.1"><s n="s1.1;pn1.1">Lord Phillips MR, R ex parte Quintavelle v HFEA </s></p></note><note place="foot" id="BAWE_0209d-ftnote.093"><p n="pn1.1"><s n="s1.1;pn1.1">Lord Phillips MR, R ex parte Quintavelle v HFEA </s></p></note><note place="foot" id="BAWE_0209d-ftnote.094"><p n="pn1.1"><s n="s1.1;pn1.1">Lord Phillips MR, R ex parte Quintavelle v HFEA </s></p></note><note place="foot" id="BAWE_0209d-ftnote.095"><p n="pn1.1"><s n="s1.1;pn1.1">Beverley Mulvenna, Pre-Implantation genetic diagnosis, Tissues typing and beyond: the legal implications of the Hashmi case, Medical Law International 2004, Vol. 6, pp.163-182, AB Academic Publishers, </s></p></note><note place="foot" id="BAWE_0209d-ftnote.096"><p n="pn1.1"><s n="s1.1;pn1.1">Beverley Mulvenna, Pre-Implantation genetic diagnosis, Tissues typing and beyond: the legal implications of the Hashmi case, Medical Law International 2004, Vol. 6, pp.163-182, AB Academic Publishers, </s></p></note><note place="foot" id="BAWE_0209d-ftnote.097"><p n="pn1.1"><s n="s1.2;pn1.1">Sally Sheldon and Stephen Wilkinson, Hashmi and Whitaker, an unjustifiable and misguided distinction? </s><s n="s2.2;pn1.1">Medical Law Review, 12, Summer 2004, pp.137-163, Oxford University Press 2004 </s></p></note><p n="p10.18"><s n="s1.6;p10.18">Mance's justification of HLA was inventive: <hi rend="italic">RCN v DHSS</hi><ref target="BAWE_0209d-ftnote.098"/> permits courts to hold a new scenario under legislative power should it fall within the "same genus of facts as intended by Parliament".<ref target="BAWE_0209d-ftnote.099"/> By inferring that S13(5)<ref target="BAWE_0209d-ftnote.100"/> (considers potential child's welfare before IVF treatment commences) could include benefits created by the prospective child saving another; and that treatment services must "have regard to prospective parents and society's concern for others";<ref target="BAWE_0209d-ftnote.101"/> he justified placing HLA within the same genus. </s><s n="s2.6;p10.18">This was "plucked out of thin air",<ref target="BAWE_0209d-ftnote.102"/> a meaningless generality with little value, that focuses not on the child's benefit; but societal gain. </s><s n="s3.6;p10.18">This use of S13(5)<ref target="BAWE_0209d-ftnote.103"/> is inconsistent with Parliamentary intention:<ref target="BAWE_0209d-ftnote.104"/> it is normally used to deny treatment to inappropriate candidates. </s><s n="s4.6;p10.18">Furthermore, as the HFEA did not regard PGD/HLA to be similar; the judgement "disregard[s] the fundamentally different purpose" of each test; advancing unjustifiable generalisations that destroy the precision and integrity of the regulatory regime. </s><s n="s5.6;p10.18">The genus argument, whilst supported with evidence (Hansard, Ministerial Advice), promotes a vague and speculative stance that moves beyond the normal parameters of judicial creativity; and is at risk of becoming a warrant for judges to promote their own moral standpoints. </s><s n="s6.6;p10.18">It is a licence to extend law on an ad hoc, and 'as needed' basis that may lead to a slippery slope; particularly as it has been undemocratically developed by those with little expertise, who clearly have very different ideas on why or how HLA should be justified, and even if it is possible under existing regulation. </s></p><note place="foot" id="BAWE_0209d-ftnote.098"><p n="pn1.1"><s n="s1.1;pn1.1">Royal college of Nursing v Department of health and social security </s></p></note><note place="foot" id="BAWE_0209d-ftnote.099"><p n="pn1.1"><s n="s1.1;pn1.1">Mance LJ, R ex parte Quintavelle v HFEA </s></p></note><note place="foot" id="BAWE_0209d-ftnote.100"><p n="pn1.1"><s n="s1.1;pn1.1">S13(5) HFE Act 1990 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.101"><p n="pn1.1"><s n="s1.1;pn1.1">Mance LJ, R ex parte Quintavelle v HFEA </s></p></note><note place="foot" id="BAWE_0209d-ftnote.102"><p n="pn1.1"><s n="s1.1;pn1.1">Beverley Mulvenna, Pre-Implantation genetic diagnosis, Tissues typing and beyond: the legal implications of the Hashmi case, Medical Law International 2004, Vol. 6, pp.163-182, AB Academic Publishers, </s></p></note><note place="foot" id="BAWE_0209d-ftnote.103"><p n="pn1.1"><s n="s1.1;pn1.1">S13(5) HFE Act 1990 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.104"><p n="pn1.1"><s n="s1.2;pn1.1">Idea from Sally Sheldon and Stephen Wilkinson, Hashmi and Whitaker, an unjustifiable and misguided distinction? </s><s n="s2.2;pn1.1">Medical Law Review, 12, Summer 2004, pp.137-163, Oxford University Press 2004 </s></p></note><p n="p11.18"><s n="s1.6;p11.18">The consequences of <hi rend="italic">Hashmi</hi> should not be underestimated. </s><s n="s2.6;p11.18">Effectively, where PGD is used, the HFEA can authorise the "selection of embryos for blue eyes, blonde hair or desired sex, without reference to Parliament".<ref target="BAWE_0209d-ftnote.105"/> Could this really have been Parliament's intention: to <hi rend="italic">delegate</hi> this form of <hi rend="italic">ethical responsibility</hi> to an unelected regulator? </s><s n="s3.6;p11.18">Brownsword suggests that when Phillips justifies HLA and PGD as methods to ensure embryos are "suitable for the purpose of being placed within [women]"<ref target="BAWE_0209d-ftnote.106"/> (free from "defect[s]"<ref target="BAWE_0209d-ftnote.107"/>), suitability becomes "equated with fitness for such purposes as the (consumer) parents may specify".<ref target="BAWE_0209d-ftnote.108"/> It is a dangerous and undemocratic advancement, illustrating the law's inability to evolve to new situations, and an unjustifiable extension of an "outdated" statute through "constitutionally undesirable means".<ref target="BAWE_0209d-ftnote.109"/> The court struggle to justify their proposition, advancing feeble explanations that are "at odds with the...statutory construction".<ref target="BAWE_0209d-ftnote.110"/> It illustrates "once again, the need for urgent review",<ref target="BAWE_0209d-ftnote.111"/> to maintain regulatory connection and ensure issues are "debated and legislated in the correct forum"; rather than placing the emphasis on the HFEA and courts to develop law. </s><s n="s4.6;p11.18"><hi rend="italic">Hashmi</hi> leaves this and future issues with the HFEA for "case-by-case decision[s]",<ref target="BAWE_0209d-ftnote.112"/> prolonging uncertainty and rendering it "unaccountable".<ref target="BAWE_0209d-ftnote.113"/> It empowers the HFEA to licence HLA with "discretion";<ref target="BAWE_0209d-ftnote.114"/> implying Parliament delegated authority to "decide what is legally and morally permissible;"<ref target="BAWE_0209d-ftnote.115"/> allowing contentious ethical decisions to be decided by a statutory regulator without opportunity for debate; a situation which "raises serious questions...[of]...legitimacy".<ref target="BAWE_0209d-ftnote.116"/> It is a very unusual scenario that demands review, particularly because of the HFEA's close affiliation with industry and science. </s><s n="s5.6;p11.18">It is at risk from "undue influence,"<ref target="BAWE_0209d-ftnote.117"/> particularly when the HFEA operations are funded through licensing, necessitating 'productive' commercial relationships. </s><s n="s6.6;p11.18">In chorus, the STC's<ref target="BAWE_0209d-ftnote.118"/> recent report suggests the HFEA must be reformed or "abolished",<ref target="BAWE_0209d-ftnote.119"/> a position welcomed by the BSC.<ref target="BAWE_0209d-ftnote.120"/> "Empowering competing professionals to be part of a licensing process was not particularly sound". <ref target="BAWE_0209d-ftnote.121"/> </s></p><note place="foot" id="BAWE_0209d-ftnote.105"><p n="pn1.1"><s n="s1.2;pn1.1">Confirmed by the HFEA when asked by Law Lords during the Hearing into Fertility Regulation, Tuesday, 8th March. </s><s n="s2.2;pn1.1">Sourced from Sourced from the CORE pressure group; online at core.org, 2004: <seg type="URL" n="http://www.corethics.org/document.asp?id=f130305.txt&amp;se=3&amp;st=4"/> </s></p></note><note place="foot" id="BAWE_0209d-ftnote.106"><p n="pn1.1"><s n="s1.1;pn1.1">Lord Phillips MR, R ex parte Quintavelle v HFEA </s></p></note><note place="foot" id="BAWE_0209d-ftnote.107"><p n="pn1.1"><s n="s1.1;pn1.1">Lord Phillips MR, R ex parte Quintavelle v HFEA </s></p></note><note place="foot" id="BAWE_0209d-ftnote.108"><p n="pn1.1"><s n="s1.1;pn1.1">ROGER BROWNSWORD, REGULATING HUMAN GENETICS: NEW DILEMMAS FOR A NEW MILLENNIUM, Medical Law Review, 12, Spring, pp. 14 - 39 © Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.109"><p n="pn1.1"><s n="s1.1;pn1.1">Beverley Mulvenna, Pre-Implantation genetic diagnosis, Tissues typing and beyond: the legal implications of the Hashmi case, Medical Law International 2004, Vol. 6, pp.163-182, AB Academic Publishers, </s></p></note><note place="foot" id="BAWE_0209d-ftnote.110"><p n="pn1.1"><s n="s1.1;pn1.1">Beverley Mulvenna, Pre-Implantation genetic diagnosis, Tissues typing and beyond: the legal implications of the Hashmi case, Medical Law International 2004, Vol. 6, pp.163-182, AB Academic Publishers, </s></p></note><note place="foot" id="BAWE_0209d-ftnote.111"><p n="pn1.1"><s n="s1.1;pn1.1">Beverley Mulvenna, Pre-Implantation genetic diagnosis, Tissues typing and beyond: the legal implications of the Hashmi case, Medical Law International 2004, Vol. 6, pp.163-182, AB Academic Publishers, </s></p></note><note place="foot" id="BAWE_0209d-ftnote.112"><p n="pn1.1"><s n="s1.1;pn1.1">ROGER BROWNSWORD, REGULATING HUMAN GENETICS: NEW DILEMMAS FOR A NEW MILLENNIUM, Medical Law Review, 12, Spring, pp. 14 - 39 © Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.113"><p n="pn1.1"><s n="s1.1;pn1.1">ROGER BROWNSWORD, REGULATING HUMAN GENETICS: NEW DILEMMAS FOR A NEW MILLENNIUM, Medical Law Review, 12, Spring, pp. 14 - 39 © Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.114"><p n="pn1.1"><s n="s1.2;pn1.1">Sally Sheldon and Stephen Wilkinson, Hashmi and Whitaker, an unjustifiable and misguided distinction? </s><s n="s2.2;pn1.1">Medical Law Review, 12, Summer 2004, pp.137-163, Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.115"><p n="pn1.1"><s n="s1.1;pn1.1">Beverley Mulvenna, Pre-Implantation genetic diagnosis, Tissues typing and beyond: the legal implications of the Hashmi case, Medical Law International 2004, Vol. 6, pp.163-182, AB Academic Publishers, </s></p></note><note place="foot" id="BAWE_0209d-ftnote.116"><p n="pn1.1"><s n="s1.1;pn1.1">Beverley Mulvenna, Pre-Implantation genetic diagnosis, Tissues typing and beyond: the legal implications of the Hashmi case, Medical Law International 2004, Vol. 6, pp.163-182, AB Academic Publishers, </s></p></note><note place="foot" id="BAWE_0209d-ftnote.117"><p n="pn1.1"><s n="s1.1;pn1.1">Robert G. Lee and Derek Morgan, Human Fertilisation and Embryology, Regulating the Reproductive Revolution, Blackstone Press Limited, 1st Edition, printed in 2001 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.118"><p n="pn1.1"><s n="s1.1;pn1.1">Science and Technology Committee </s></p></note><note place="foot" id="BAWE_0209d-ftnote.119"><p n="pn1.1"><s n="s1.1;pn1.1">Science and Technology Committee Report on Reproductive Technologies, March 24th 2005 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.120"><p n="pn1.1"><s n="s1.1;pn1.1">British Fertility Society </s></p></note><note place="foot" id="BAWE_0209d-ftnote.121"><p n="pn1.1"><s n="s1.1;pn1.1">Lord Robert Winston, sourced from Robert G. Lee and Derek Morgan, Human Fertilisation and Embryology, Regulating the Reproductive Revolution, Blackstone Press Limited, 1st Edition, printed in 2001 </s></p></note><p n="p12.18"><s n="s1.4;p12.18">This <hi rend="italic">'quick-fix'</hi> denied HLA a proper forum; depriving later, equally justifiable cases from its potential benefits. </s><s n="s2.4;p12.18">In <hi rend="italic">Whitaker</hi>, parents wished to use HLA to provide tissue for a child suffering with DBA.<ref target="BAWE_0209d-ftnote.122"/> However, as DBA was "sporadic"<ref target="BAWE_0209d-ftnote.123"/> rather than hereditary, PGD was denied under <hi rend="italic">Hashmi</hi> as the risk to their embryos was no greater than natural conception. </s><s n="s3.4;p12.18">The HFEA distinguished <hi rend="italic">Whitaker</hi> because: it was wrong to create a child for a particular purpose/procedure; whilst PGD may create unknown health risks. </s><s n="s4.4;p12.18">Realistically, only the latter argument distinguishes Whittaker from Hashmi: if the potentially dangerous PGD procedure is used to prevent a child from being born with a serious illness, the "benefits outweigh the risks",<ref target="BAWE_0209d-ftnote.124"/> therefore you might as well conduct HLA. Yet when PGD is applied purely to use HLA, there is no initial risk; therefore the child may be subjected to "something harmful".<ref target="BAWE_0209d-ftnote.125"/> Yet, an equally valid argument exists in support of HLA: surely the benefit for the <hi rend="italic">Whitaker</hi>'s potential child is "existing rather than not existing"? <ref target="BAWE_0209d-ftnote.126"/> </s></p><note place="foot" id="BAWE_0209d-ftnote.122"><p n="pn1.1"><s n="s1.1;pn1.1">Diamond Blackfan Anaemia </s></p></note><note place="foot" id="BAWE_0209d-ftnote.123"><p n="pn1.1"><s n="s1.1;pn1.1">Beverley Mulvenna, Pre-Implantation genetic diagnosis, Tissues typing and beyond: the legal implications of the Hashmi case, Medical Law International 2004, Vol. 6, pp.163-182, AB Academic Publishers, </s></p></note><note place="foot" id="BAWE_0209d-ftnote.124"><p n="pn1.1"><s n="s1.2;pn1.1">Sally Sheldon and Stephen Wilkinson, Hashmi and Whitaker, an unjustifiable and misguided distinction? </s><s n="s2.2;pn1.1">Medical Law Review, 12, Summer 2004, pp.137-163, Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.125"><p n="pn1.1"><s n="s1.2;pn1.1">Sally Sheldon and Stephen Wilkinson, Hashmi and Whitaker, an unjustifiable and misguided distinction? </s><s n="s2.2;pn1.1">Medical Law Review, 12, Summer 2004, pp.137-163, Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.126"><p n="pn1.1"><s n="s1.2;pn1.1">Sally Sheldon and Stephen Wilkinson, Hashmi and Whitaker, an unjustifiable and misguided distinction? </s><s n="s2.2;pn1.1">Medical Law Review, 12, Summer 2004, pp.137-163, Oxford University Press 2004 </s></p></note><p n="p13.18"><s n="s1.4;p13.18">Whilst <hi rend="italic">Hashmi</hi> was <hi rend="italic">principally</hi> correct; I suggest it is morally indistinguishable from <hi rend="italic">Whitaker</hi>. </s><s n="s2.4;p13.18">Kantian theory suggests we should never treat people as 'means,' but surely this only applies if we treat people "solely or merely as means".<ref target="BAWE_0209d-ftnote.127"/> It is acceptable to create a child as a playmate, to "mend a broken marriage",<ref target="BAWE_0209d-ftnote.128"/> or to "buy, buy, buy":<ref target="BAWE_0209d-ftnote.129"/> most conceptions are for selfish reasons rather than to extend humanity. </s><s n="s3.4;p13.18">There are worse reasons to create a child than to save another. </s><s n="s4.4;p13.18">Whilst positively selecting characteristics is a dangerous and now <hi rend="italic">real</hi> first step towards 'designer babies,' there is no reason why selection cannot occur in some instances and not others: "fundamental moral difference [exists] between designer and saviour babies". <ref target="BAWE_0209d-ftnote.130"/><hi rend="italic">Hashmi</hi> assumes that 'saviour babies' are morally acceptable only in specific scenarios, denying opportunity for real, democratic debate; and in paying 'lip-service' to restraint and caution, draws perhaps an "unjustifiable and misguided distinction"<ref target="BAWE_0209d-ftnote.131"/> that is "legally untenable." <ref target="BAWE_0209d-ftnote.132"/> </s></p><note place="foot" id="BAWE_0209d-ftnote.127"><p n="pn1.1"><s n="s1.2;pn1.1">Sally Sheldon and Stephen Wilkinson, Hashmi and Whitaker, an unjustifiable and misguided distinction? </s><s n="s2.2;pn1.1">Medical Law Review, 12, Summer 2004, pp.137-163, Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.128"><p n="pn1.1"><s n="s1.2;pn1.1">Sally Sheldon and Stephen Wilkinson, Hashmi and Whitaker, an unjustifiable and misguided distinction? </s><s n="s2.2;pn1.1">Medical Law Review, 12, Summer 2004, pp.137-163, Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.129"><p n="pn1.1"><s n="s1.2;pn1.1">Sally Sheldon and Stephen Wilkinson, Hashmi and Whitaker, an unjustifiable and misguided distinction? </s><s n="s2.2;pn1.1">Medical Law Review, 12, Summer 2004, pp.137-163, Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.130"><p n="pn1.1"><s n="s1.2;pn1.1">Sally Sheldon and Stephen Wilkinson, Hashmi and Whitaker, an unjustifiable and misguided distinction? </s><s n="s2.2;pn1.1">Medical Law Review, 12, Summer 2004, pp.137-163, Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.131"><p n="pn1.1"><s n="s1.2;pn1.1">Sally Sheldon and Stephen Wilkinson, Hashmi and Whitaker, an unjustifiable and misguided distinction? </s><s n="s2.2;pn1.1">Medical Law Review, 12, Summer 2004, pp.137-163, Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.132"><p n="pn1.1"><s n="s1.2;pn1.1">Sally Sheldon and Stephen Wilkinson, Hashmi and Whitaker, an unjustifiable and misguided distinction? </s><s n="s2.2;pn1.1">Medical Law Review, 12, Summer 2004, pp.137-163, Oxford University Press 2004 </s></p></note><p n="p14.18"><s n="s1.13;p14.18">A comprehensive review of the parameters, and how we regulate fertility is required; a review that must remain ongoing.<ref target="BAWE_0209d-ftnote.133"/> Law focuses too keenly on protecting controversial, 'head-line' treatments; we must redress the balance, and focus as Warnock suggested on quality, protection, and safety. </s><s n="s2.13;p14.18">It is "illogical"<ref target="BAWE_0209d-ftnote.134"/> to "single out just one kind of reproductive medicine...for such...elaborate regulation". </s><s n="s3.13;p14.18">There is "no control over the...bulk of...reproductive practice".<ref target="BAWE_0209d-ftnote.135"/> GIFT<ref target="BAWE_0209d-ftnote.136"/> is more likely to result in "multiple pregnancy",<ref target="BAWE_0209d-ftnote.137"/> standards of tubal surgery are "much more variable",<ref target="BAWE_0209d-ftnote.138"/> whilst Hyper-stimulation<ref target="BAWE_0209d-ftnote.139"/> is "certainly the most dangerous reproductive technique";<ref target="BAWE_0209d-ftnote.140"/> yet all are unregulated. </s><s n="s4.13;p14.18">"IVF is no more dangerous than other techniques",<ref target="BAWE_0209d-ftnote.141"/> yet because it is morally controversial we loose sight of what must be our principle aim: safety. </s><s n="s5.13;p14.18">Regulating such a large area of reproductive medicine would be "very expensive";<ref target="BAWE_0209d-ftnote.142"/> whilst it is clear the HFEA "has been chronically short of money".<ref target="BAWE_0209d-ftnote.143"/> This is the reality of medical regulation: it must be situated in context with policy, economics and resource availability. </s><s n="s6.13;p14.18">This is not a problem that will vaporise. </s><s n="s7.13;p14.18">As medicine develops new challenges confront us. </s><s n="s8.13;p14.18">Society is also changing; and in the advent of Human Rights and liberalisation, we must face new issues, e.g. assisted homosexual conceptions. </s><s n="s9.13;p14.18">The HFE does not focus enough on "improving clinical standards".<ref target="BAWE_0209d-ftnote.144"/> We are a developed country: no shortage of resources should prevent proper regulation of <hi rend="italic">all</hi> reproductive medicine; existing and future. </s><s n="s10.13;p14.18">Fertility is a global industry regulated in different ways and degrees. </s><s n="s11.13;p14.18">The <hi rend="italic">Whitaker's</hi> and eight other couples, who were all denied treatment, received HLA in other jurisdictions. </s><s n="s12.13;p14.18">We must further our co-operation, and produce an extended legal regime that is reviewed regularly; a product of proper democratic debate that operates comfortably within safe and respected boundaries. </s><s n="s13.13;p14.18">Existing regulation, limited to specific applications and supplemented "on an ad hoc basis"<ref target="BAWE_0209d-ftnote.145"/> "cannot...adapt to evolving science".<ref target="BAWE_0209d-ftnote.146"/> It is "technology-led",<ref target="BAWE_0209d-ftnote.147"/> rather than teleological, "reflecting what scientists regard as respectable".<ref target="BAWE_0209d-ftnote.148"/> When, "commercial fortunes ride [on] matters of life and death",<ref target="BAWE_0209d-ftnote.149"/> is this acceptable? </s></p><note place="foot" id="BAWE_0209d-ftnote.133"><p n="pn1.1"><s n="s1.1;pn1.1">Robert G. Lee and Derek Morgan suggest every 5 years law should be reviewed and updated; Human Fertilisation and Embryology, Regulating the Reproductive Revolution, Blackstone Press Limited, 1st Edition, printed in 2001 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.134"><p n="pn1.1"><s n="s1.1;pn1.1">Lord Robert Winston, sourced from Robert G. Lee and Derek Morgan, Human Fertilisation and Embryology, Regulating the Reproductive Revolution, Blackstone Press Limited, 1st Edition, printed in 2001 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.135"><p n="pn1.1"><s n="s1.1;pn1.1">Lord Robert Winston, sourced from Robert G. Lee and Derek Morgan, Human Fertilisation and Embryology, Regulating the Reproductive Revolution, Blackstone Press Limited, 1st Edition, printed in 2001 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.136"><p n="pn1.1"><s n="s1.1;pn1.1">Gamete Intra-fallopian Transfer </s></p></note><note place="foot" id="BAWE_0209d-ftnote.137"><p n="pn1.1"><s n="s1.1;pn1.1">Robert G. Lee and Derek Morgan, Human Fertilisation and Embryology, Regulating the Reproductive Revolution, Blackstone Press Limited, 1st Edition, printed in 2001 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.138"><p n="pn1.1"><s n="s1.1;pn1.1">Robert G. Lee and Derek Morgan, Human Fertilisation and Embryology, Regulating the Reproductive Revolution, Blackstone Press Limited, 1st Edition, printed in 2001 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.139"><p n="pn1.1"><s n="s1.1;pn1.1">Unlicensed Procedure to stimulate ovulation without IVF Treatment </s></p></note><note place="foot" id="BAWE_0209d-ftnote.140"><p n="pn1.1"><s n="s1.1;pn1.1">Robert G. Lee and Derek Morgan, Human Fertilisation and Embryology, Regulating the Reproductive Revolution, Blackstone Press Limited, 1st Edition, printed in 2001 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.141"><p n="pn1.1"><s n="s1.1;pn1.1">Lord Robert Winston, sourced from Robert G. Lee and Derek Morgan, Human Fertilisation and Embryology, Regulating the Reproductive Revolution, Blackstone Press Limited, 1st Edition, printed in 2001 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.142"><p n="pn1.1"><s n="s1.1;pn1.1">Robert G. Lee and Derek Morgan, Human Fertilisation and Embryology, Regulating the Reproductive Revolution, Blackstone Press Limited, 1st Edition, printed in 2001 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.143"><p n="pn1.1"><s n="s1.1;pn1.1">Lord Robert Winston, sourced from Robert G. Lee and Derek Morgan, Human Fertilisation and Embryology, Regulating the Reproductive Revolution, Blackstone Press Limited, 1st Edition, printed in 2001 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.144"><p n="pn1.1"><s n="s1.1;pn1.1">Lord Robert Winston, sourced from Robert G. Lee and Derek Morgan, Human Fertilisation and Embryology, Regulating the Reproductive Revolution, Blackstone Press Limited, 1st Edition, printed in 2001 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.145"><p n="pn1.1"><s n="s1.1;pn1.1">SAMANTHA HALLIDAY AND DEBORAH LYNN STEINBERG, THE REGULATED GENE: NEW LEGAL DILEMMAS, Medical Law Review, 12, Spring, pp. 2 - 13 © Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.146"><p n="pn1.1"><s n="s1.1;pn1.1">SAMANTHA HALLIDAY AND DEBORAH LYNN STEINBERG, THE REGULATED GENE: NEW LEGAL DILEMMAS, Medical Law Review, 12, Spring, pp. 2 - 13 © Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.147"><p n="pn1.1"><s n="s1.1;pn1.1">SAMANTHA HALLIDAY AND DEBORAH LYNN STEINBERG, THE REGULATED GENE: NEW LEGAL DILEMMAS, Medical Law Review, 12, Spring, pp. 2 - 13 © Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.148"><p n="pn1.1"><s n="s1.1;pn1.1">SAMANTHA HALLIDAY AND DEBORAH LYNN STEINBERG, THE REGULATED GENE: NEW LEGAL DILEMMAS, Medical Law Review, 12, Spring, pp. 2 - 13 © Oxford University Press 2004 </s></p></note><note place="foot" id="BAWE_0209d-ftnote.149"><p n="pn1.1"><s n="s1.1;pn1.1">ROGER BROWNSWORD, REGULATING HUMAN GENETICS: NEW DILEMMAS FOR A NEW MILLENNIUM, Medical Law Review, 12, Spring, pp. 14 - 39 © Oxford University Press 2004 </s></p></note><p n="p15.18"><s rend="bold" n="s1.1;p15.18">N.B. </s></p><p n="p16.18"><s n="s1.1;p16.18">As this Assignment was written two important developments were pending: </s></p><p rend="bulleted" n="p17.18"><s n="s1.1;p17.18">Hashmi decision is awaiting review by the House of Lords </s></p><p rend="bulleted" n="p18.18"><s n="s1.1;p18.18">The Commons Science and Technology Committee Report on Reproductive Technologies was published on March 24 <hi rend="sup">th</hi> 2005 </s></p></div1></body><back><div1 type="bibliography"><head rend="bold">Bibliography</head><div2 type="bibliography"><head>Books...<hi rend="italic">Sourced from the University of </hi><name type="university"/><hi rend="italic"> Library</hi></head><p rend="bold">Source 1</p><p>Title: Human Fertilisation and Embryology, Regulating the Reproductive Revolution</p><p>Author: Robert G. Lee and Derek Morgan</p><p>Other: </p><p>Publisher: Blackstone Press Limited</p><p>Date: 1st Edition, printed in 2001</p><p>Source: University of <name type="university"/> Library</p><p rend="bold">Source 2</p><p>Title: Law, Fertility and Reproduction</p><p>Author: Gillian Douglas </p><p>Other: </p><p>Publisher: London, Sweet and Maxwell</p><p>Date: 1st Edition, printed in 1991</p><p>Source: University of <name type="university"/> Library</p><p rend="bold">Source 3</p><p>Title: A question of life: the Warnock report on Human Fertilisation and Embryology; on the Report of the Committee of Inquiry into Human Fertilisation and Embryology</p><p>Author: Mary Warnock, Chairwomen of Committee of Inquiry into Human Fertilisation and Embryology</p><p>Publisher: Oxford : Blackwell</p><p>Date: 1st Edition, 1985</p><p>Source: University of <name type="university"/> Library</p></div2><div2 type="bibliography"><head>Case Reports...<hi rend="italic">Sourced from Lexis Nexis: </hi><seg type="URL" n="www.lexisnexis.co.uk"/></head><p rend="bold">Source 4</p><p>R (Quintavalle) v HFEA (2003) EWCA Civ. 667</p></div2><div2 type="bibliography"><head>Journals...<hi rend="italic">Sourced from the University of </hi><name type="university"/><hi rend="bold italic"> Library</hi></head><p rend="bold">Source 5</p><p>Title: Reconstructing the HFEA 1990: is blood thicker than water</p><p>Author: Julie Wallbank, school of law, university of Leeds</p><p>Other: Child and Family Law Quarterly, Volume 16, Number 4</p><p>Publisher: Jordan Publishing </p><p>Date: 2004</p><p>Source: University of <name type="university"/> Library</p></div2><div2 type="bibliography"><head>Journals...<hi rend="italic">Sourced from the British Library, London</hi></head><p rend="bold">Source 6</p><p>Title: Pre-Implantation genetic diagnosis, Tissues typing and beyond: the legal implications of the Hashmi case</p><p>Author: Beverley Mulvenna</p><p>Publisher: AB Academic Publishers</p><p>Other: Medical Law International, Vol. 6, pp.163-182</p><p>Date: 2004</p><p>Source: British Library, London </p></div2><div2 type="bibliography"><head>Electronic Resources...<hi rend="italic">Sourced through the University of </hi><name type="university"/><hi rend="italic"> Library</hi></head><p rend="bold">Source 7</p><p>Title: Hashmi and Whitaker, an unjustifiable and misguided</p><p>Publication: Medical Law Review, 12, pp.137-163 - Online</p><p>Author: Sally Sheldon and Stephen Wilkinson</p><p>Publisher: Oxford University Press</p><p>Date: Summer 2004</p><p rend="bold">Source 8</p><p>Title: REGULATING HUMAN GENETICS: NEW DILEMMAS FOR A NEW MILLENNIUM</p><p>Publication: Medical Law Review, 12, Spring, pp. 14 - 39 - Online</p><p>Author: ROGER BROWNSWORD</p><p>Publisher: Oxford University Press</p><p>Date: Spring 2004</p><p rend="bold">Source 9</p><p>Title: A comparative approach to the regulation of Human Embryonic Stem Cell research in Europe</p><p>Publication: Medical Law Review, 12, Spring, pp. 40-69 - Online</p><p>Author: SAMANTHA HALLIDAY </p><p>Publisher: Oxford University Press</p><p>Date: Spring 2004</p><p rend="bold">Source 10</p><p>Title: REGULATING HUMAN GENETICS: NEW DILEMMAS FOR A NEW MILLENNIUM</p><p>Publication: Medical Law Review, 12, Spring, pp. 2 - 13 - Online</p><p>Author: SAMANTHA HALLIDAY AND DEBORAH LYNN STEINBERG</p><p>Publisher: Oxford University Press</p><p>Date: Spring 2004</p><p rend="bold">Source 11</p><p>Title: Beyond the HFEA 1990 - The Regulation of Stem cell Research in the UK</p><p>Publication: Medical Law Review, 10 Summer 2002, pp132-164 - Online</p><p>Author: Aurora Plomer </p><p>Publisher: Oxford University Press</p><p>Date: Summer 2002</p><p rend="bold">Source 12</p><p>Title: Regulating the Reproduction business </p><p>Publication: Medical Law Review, 7, Summer 1999, pp. 166-193 - Online</p><p>Author: Margaret Brazier</p><p>Publisher: Oxford University Press</p><p>Date: Summer 1999</p><p rend="bold">Source 13</p><p>Title: Reproductive Cloning in the UK </p><p>Publication: Medical Law Review, pp. 327-329 - Online</p><p>Author: Unstated Commentary</p><p>Publisher: Oxford University Press</p><p>Date: 2002 </p><p rend="bold">Source 14</p><p>Title: Cloning (Cell-Nuclear Replacement): The Scope of the Human Fertilisation and Embryology Act </p><p>Publication: Medical Law Review, pp.135-138 - Online</p><p>Author: Unstated Commentary </p><p>Publisher: Oxford University Press</p><p>Date: 2003 </p></div2><div2 type="bibliography"><head>Internet Resources</head><p rend="bold">Source 15</p><p>Title: Hansard Society Online Consultation on Human Reproductive Technologies and the Law Commissioned by the Science and Technology Select Committee Summary Report</p><p>Publication: As Above </p><p>Author: Hansard Society </p><p>Publisher: Hansard Society </p><p>Date: March 2004</p><p>Source: <seg type="URL" n="www.hansardsociety.org.uk"/></p><p rend="bold">Source 16</p><p>Title: Untitled Commentary on HFE Act 1990 </p><p>Publication: Website page </p><p>Author: CORE Group </p><p>Publisher: CORE Group </p><p>Date: 2004</p><p>Source: <seg type="URL" n="http://www.corethics.org/document.asp?id=f130305.txt&amp;se=3&amp;st=4"/></p><p rend="bold">Source 17</p><p>Title: The Commons Science and Technology Committee</p><p>Publication: Website page </p><p>Author: BBC </p><p>Publisher: BBC News Online Edition </p><p>Date: March 24<hi rend="sup">th</hi> 2005</p><p>Source: <seg type="URL" n="www.bbc.co.uk/news"/></p><p rend="bold">Source 18</p><p>Title: The Commons Science and Technology Committee Terms of Reference</p><p>Publication: Website page </p><p>Author: UK Parliament Publications </p><p>Publisher: UK Parliament Publications </p><p>Date: Unlisted</p><p>Source: <seg type="URL" n="http://www.publications.parliament.uk/pa/cm200304/cmselect/cmsctech/c599"/>- i/uc59902.htm</p><p rend="bold">Source 19</p><p>Title: British Fertility Society - Broad welcome for embryo screening report</p><p>Publication: Website page </p><p>Author: British Fertility Society</p><p>Publisher: British Fertility Society</p><p>Date: Unlisted</p><p>Source: <seg type="URL" n="http://www.politics.co.uk/issueoftheday/british-fertility-society-broad-welcome-embryo"/>- screening-report-$8109315.htm</p><p rend="bold">Source 20</p><p>Title: British Fertility Society - Press Release Regarding The Commons Science and Technology Committee Report of 2005</p><p>Publication: Website page </p><p>Author: British Fertility Society</p><p>Publisher: British Fertility Society</p><p>Date: Unlisted</p><p>Source: <seg type="URL" n="http://www.britishfertilitysociety.org.uk/news/pressrelease/05_03-reprotechlaw.html"/></p><p rend="bold">Source 21</p><p>Title: HFEA designer baby decision unethical, unnecessary and undemocratic</p><p>Publication: Website page </p><p>Author: Core.org</p><p>Publisher: Core.org</p><p>Date: 26 July 2004</p><p>Source: <seg type="URL" n="http://www.corethics.org/document.asp?id=f260704.txt&amp;se=3&amp;st=4"/></p><p rend="bold">Source 22</p><p>Title: UK ponders fertility reforms, IVF debate foreshadows wider rethink of ethics regulation in Britain</p><p>Publication: The Scientist - Online Edition </p><p>Author: By Philip Hunter</p><p>Publisher: The Scientist - Online Edition</p><p>Date: March 23, 2005</p><p>Source: <seg type="URL" n="http://www.biomedcentral.com/news/20050323/02"/></p></div2></div1></back></text></TEI.2>
